233 related articles for article (PubMed ID: 25750251)
1. Opportunities for translational epidemiology: the important role of observational studies to advance precision oncology.
Marrone M; Schilsky RL; Liu G; Khoury MJ; Freedman AN
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):484-9. PubMed ID: 25750251
[TBL] [Abstract][Full Text] [Related]
2. Invited commentary: driving for further evolution.
Hiatt RA
Am J Epidemiol; 2015 Apr; 181(7):459-62. PubMed ID: 25767263
[TBL] [Abstract][Full Text] [Related]
3. Translating genomic discoveries to the clinic in pediatric oncology.
Glade Bender J; Verma A; Schiffman JD
Curr Opin Pediatr; 2015 Feb; 27(1):34-43. PubMed ID: 25502895
[TBL] [Abstract][Full Text] [Related]
4. Translational research: understanding the continuum from bench to bedside.
Drolet BC; Lorenzi NM
Transl Res; 2011 Jan; 157(1):1-5. PubMed ID: 21146144
[TBL] [Abstract][Full Text] [Related]
5. Translational epidemiology in psychiatry: linking population to clinical and basic sciences.
Weissman MM; Brown AS; Talati A
Arch Gen Psychiatry; 2011 Jun; 68(6):600-8. PubMed ID: 21646577
[TBL] [Abstract][Full Text] [Related]
6. Translating Alcohol Research: Opportunities and Challenges.
Batman AM; Miles MF
Alcohol Res; 2015; 37(1):7-14. PubMed ID: 26259085
[TBL] [Abstract][Full Text] [Related]
7. Research Methods in Healthcare Epidemiology and Antimicrobial Stewardship-Observational Studies.
Snyder GM; Young H; Varman M; Milstone AM; Harris AD; Munoz-Price S
Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1141-6. PubMed ID: 27322190
[TBL] [Abstract][Full Text] [Related]
8. Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.
Siebert U; Jahn B; Rochau U; Schnell-Inderst P; Kisser A; Hunger T; Sroczynski G; Mühlberger N; Willenbacher W; Schnaiter S; Endel G; Huber L; Gastl G;
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):330-40. PubMed ID: 26354133
[TBL] [Abstract][Full Text] [Related]
9. Evolution of the "drivers" of translational cancer epidemiology: analysis of funded grants and the literature.
Lam TK; Chang CQ; Rogers SD; Khoury MJ; Schully SD
Am J Epidemiol; 2015 Apr; 181(7):451-8. PubMed ID: 25767265
[TBL] [Abstract][Full Text] [Related]
10. Translational epidemiology: The powerful tool for precision cancer medicine.
Fu Z; Zhang R; Li P; Jia M
J Cancer Res Ther; 2019; 15(2):269-271. PubMed ID: 30964096
[TBL] [Abstract][Full Text] [Related]
11. [The emergence and development of gene expression profiling: a key component of the 3B (bench, bedside, bytes) in translational research].
Cointet JP; Mogoutov A; Bourret P; El Abed R; Cambrosio A
Med Sci (Paris); 2012 Mar; 28 Spec No 1():7-13. PubMed ID: 22494650
[TBL] [Abstract][Full Text] [Related]
12. A Future for Observational Epidemiology: Clarity, Credibility, Transparency.
Harper S
Am J Epidemiol; 2019 May; 188(5):840-845. PubMed ID: 30877294
[TBL] [Abstract][Full Text] [Related]
13. Translating cancer genomes and transcriptomes for precision oncology.
Roychowdhury S; Chinnaiyan AM
CA Cancer J Clin; 2016; 66(1):75-88. PubMed ID: 26528881
[TBL] [Abstract][Full Text] [Related]
14. The Dawning of Translational Breast Cancer: From Bench to Bedside.
Chen X; Fan S; Song E
Adv Exp Med Biol; 2017; 1026():1-25. PubMed ID: 29282677
[TBL] [Abstract][Full Text] [Related]
15. Emerging Translation of Regenerative Therapies.
Allickson JG
Clin Pharmacol Ther; 2017 Jan; 101(1):28-30. PubMed ID: 27806427
[TBL] [Abstract][Full Text] [Related]
16. "Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities.
Lam TK; Spitz M; Schully SD; Khoury MJ
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):181-8. PubMed ID: 23322363
[TBL] [Abstract][Full Text] [Related]
17. Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research.
Elena JW; Travis LB; Simonds NI; Ambrosone CB; Ballard-Barbash R; Bhatia S; Cerhan JR; Hartge P; Heist RS; Kushi LH; Lash TL; Morton LM; Onel K; Pierce JP; Robison LL; Rowland JH; Schrag D; Sellers TA; Seminara D; Shu XO; Thomas NE; Ulrich CM; Freedman AN
J Natl Cancer Inst; 2013 Jan; 105(2):85-94. PubMed ID: 23197494
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in molecular imaging biomarkers in cancer: application of bench to bedside technologies.
van der Meel R; Gallagher WM; Oliveira S; O'Connor AE; Schiffelers RM; Byrne AT
Drug Discov Today; 2010 Feb; 15(3-4):102-14. PubMed ID: 20035896
[TBL] [Abstract][Full Text] [Related]
19. Translational modeling and simulation approaches for molecularly targeted small molecule anticancer agents from bench to bedside.
Yamazaki S; Spilker ME; Vicini P
Expert Opin Drug Metab Toxicol; 2016; 12(3):253-65. PubMed ID: 26799750
[TBL] [Abstract][Full Text] [Related]
20. The Master Observational Trial: A New Class of Master Protocol to Advance Precision Medicine.
Dickson D; Johnson J; Bergan R; Owens R; Subbiah V; Kurzrock R
Cell; 2020 Jan; 180(1):9-14. PubMed ID: 31951522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
